These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 650709)

  • 1. Effects of combined radiotherapy and immunotherapy with the use of pyran copolymer on murine fibrosarcoma.
    Collins AL; Song CW
    J Natl Cancer Inst; 1978 Jun; 60(6):1477-81. PubMed ID: 650709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages.
    Harmel RP; zbar B
    J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
    Milas L; Hersh EM; Hunter N
    Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition and enhancement of Friend leukemia virus by pyran copolymer.
    Schuller GB; Morahan PS; Snodgrass M
    Cancer Res; 1975 Aug; 35(8):1915-20. PubMed ID: 1149015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined radiotherapy and Corynebacterium parvum treatment of a murine fibrosarcoma.
    Collins AL; Song CW
    Radiology; 1977 Oct; 125(1):235-41. PubMed ID: 897175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum.
    Milas L; Hunter B; Mason K; Grdina D; Withers H
    J Natl Cancer Inst; 1975 Apr; 54(4):895-902. PubMed ID: 1127718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined effect of radiotherapy and neuraminidase-treated tumor cells on 3-methylcholanthrene-induced fibrosarcoma.
    So SK; Song CW; Rios A; Simmons RL
    J Surg Oncol; 1977; 9(6):527-40. PubMed ID: 592852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)].
    Mukai M; Ando K; Koike S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology of the host response to Lewis lung carcinoma: modulation by pyran.
    Snodgrass MJ; Morahan PS; Kaplan AM
    J Natl Cancer Inst; 1975 Aug; 55(2):455-62. PubMed ID: 1159827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage involvement in the protective effect of pyran copolymer against the Madison lung carcinoma (M109).
    Schultz RM; Papamatheakis JD; Luetzeler J; Ruiz P; Chirigos MA
    Cancer Res; 1977 Feb; 37(2):358-64. PubMed ID: 832262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 5-aza-2'-deoxycytidine in combination with the biochemical modulator thymidine or the immune modulator pyran copolymer on L1210 leukemia-bearing mice.
    Zaharko DS; Covey JM
    Cancer Treat Rep; 1984 Oct; 68(10):1255-64. PubMed ID: 6084549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
    Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptococcus neoformans: in vivo protection of mice by pretreatment with pyran copolymer.
    Fromtling RA; Shadomy HJ; Kaplan AM
    Mycopathologia; 1984 Mar; 85(1-2):3-7. PubMed ID: 6374462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity.
    Puccetti P; Santoni A; Riccardi C; Holden HT; Herberman RB
    Int J Cancer; 1979 Dec; 24(6):819-25. PubMed ID: 232496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased therapeutic efficacy and reduced toxicity of doxorubicin linked to pyran copolymer via the side chain of the drug.
    Zunino F; Pratesi G; Pezzoni G
    Cancer Treat Rep; 1987 Apr; 71(4):367-73. PubMed ID: 3829013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
    Milas L; Hunter N; Withers HR
    Cancer Res; 1974 Mar; 34(3):613-20. PubMed ID: 4590922
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination].
    Mukai M; Ando K; Koike S; Ishikawa T; Ryu M; Nagashima T; Nagao K; Isono K
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):556-62. PubMed ID: 3954378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of immunotherapy with neuraminidase-treated tumor cell vaccine in mice bearing established 3-methylcholanthrene-induced sarcomas.
    Spence RJ; Simon RM; Baker AR
    J Natl Cancer Inst; 1978 Feb; 60(2):451-9. PubMed ID: 621758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced bone marrow toxicity of neocarzinostatin by conjugation with divinyl ether-maleic acid copolymer.
    Yamamoto H; Miki T; Oda T; Hirano T; Sera Y; Akagi M; Maeda H
    Eur J Cancer; 1990 Mar; 26(3):253-60. PubMed ID: 2141482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of immunotherapy and chemotherapy to experimental tumors in rats.
    Hosokawa M; Sendo F; Gotoda E; Kobayashi H
    Gan; 1971 Feb; 62(1):57-60. PubMed ID: 5553381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.